AU2682299A - Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosis - Google Patents

Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosis

Info

Publication number
AU2682299A
AU2682299A AU26822/99A AU2682299A AU2682299A AU 2682299 A AU2682299 A AU 2682299A AU 26822/99 A AU26822/99 A AU 26822/99A AU 2682299 A AU2682299 A AU 2682299A AU 2682299 A AU2682299 A AU 2682299A
Authority
AU
Australia
Prior art keywords
prognosis
assessment
body fluids
cancer screening
disease stage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26822/99A
Inventor
Lynne V. Abruzzo
Edward Highsmith
Judith Stamberg
Jeffrey W. Strovel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland at Baltimore
Original Assignee
University of Maryland at Baltimore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Maryland at Baltimore filed Critical University of Maryland at Baltimore
Publication of AU2682299A publication Critical patent/AU2682299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
AU26822/99A 1998-02-16 1999-02-16 Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosis Abandoned AU2682299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7479398P 1998-02-16 1998-02-16
US60074793 1998-02-16
PCT/US1999/003302 WO1999041406A1 (en) 1998-02-16 1999-02-16 Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosis

Publications (1)

Publication Number Publication Date
AU2682299A true AU2682299A (en) 1999-08-30

Family

ID=22121731

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26822/99A Abandoned AU2682299A (en) 1998-02-16 1999-02-16 Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosis

Country Status (5)

Country Link
EP (1) EP1071808A1 (en)
JP (1) JP2002503480A (en)
AU (1) AU2682299A (en)
CA (1) CA2321259A1 (en)
WO (1) WO1999041406A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1158055A1 (en) * 2000-05-26 2001-11-28 Xu Qi University of Teaxs Laboratoire de Leucémie Chen Method for diagnosing cancers
ITMI20022743A1 (en) 2002-12-23 2004-06-24 Ist Naz Stud Cura Dei Tumori METHOD FOR DETERMINING THE RISK OF APPEARANCE, THE PRESENCE OR THE COURSE OF CANCER DISEASES.
ATE406463T1 (en) 2005-04-06 2008-09-15 Maurice Stroun METHOD FOR CANCER DIAGNOSIS USING DETECTION OF DNA AND RNA IN THE CIRCULATION
CN106940372A (en) * 2017-03-06 2017-07-11 南京中医药大学 Detect methylene blue, upper conversion nano grain modification fibrosis paper sensor of Telomerase and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830644A (en) * 1992-05-13 1998-11-03 Geron Corporation Method for screening for agents which increase telomerase activity in a cell
US5840490A (en) * 1995-06-07 1998-11-24 Mcmaster University Telomerase activity associated with hematological and colorectal malignancies

Also Published As

Publication number Publication date
WO1999041406A1 (en) 1999-08-19
CA2321259A1 (en) 1999-08-19
EP1071808A1 (en) 2001-01-31
JP2002503480A (en) 2002-02-05

Similar Documents

Publication Publication Date Title
AU6141699A (en) Immunoassay that provides for both collection of saliva and assay of saliva
AU1724000A (en) Diagnostic assay for cancer
AU2010699A (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for theiruse
AU5212199A (en) Methods and kits for diagnosing and determination of the predisposition of diseases
EP1144632A3 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU1810899A (en) Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
AU1465801A (en) Methods for cancer prognosis and diagnosis
AU2291299A (en) Promoter regions of the mouse and human telomerase rna component genes
AU2002240336A1 (en) Methods for the diagnosis and treatment of tumors employing the hepsin gene
GB2327497B (en) Diagnostic assay for cancer
AU6425800A (en) Agents for the diagnosis, prognosis and treatment of malignant diseases
EP1164838A4 (en) Screening assay for antagonists of fgfr-mediated malignant cell transformation and tumor formation
GB9811598D0 (en) Diagnosis and treatment of cancer
AU2682299A (en) Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosis
GB0011439D0 (en) Cancer diagnosis and assays for screening
EP1271152A4 (en) Method of examining cancer by assaying autoantibody against mdm2 and reagent therefor
AU3972899A (en) Analysis of gene family expression
AU4150999A (en) Method and kit for early diagnosis of cancer
AU2001243965A1 (en) Gastric emptying test-kit and method of testing gastric emptying of solid meal
AU7713498A (en) Immunoassay for the detection of cancer
EP0951484A4 (en) Colon cancer kh-1 and n3 antigens
AUPQ037799A0 (en) Methods for diagnosing and/or predicting the risk of gastric cancer
AU1198899A (en) Reagents and immunoassay for the detection and quantitative determination of mycothiol and precursors thereof
AU2002322066A1 (en) N-terminally truncated galectin-3 and antibodies for treating cancer
AU2002306600A1 (en) Sperm protein 17 for the diagnosis and treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase